Potential role for antiangiogenic proteins in the myocardial infarction repair process

Journal of Surgical Research

Volumn 116, Issue 1, 2004, Pages 156-164

  Thompson, Jess L ^a   Ryan, James A ^a   Barr, Mark L ^b,c   Franc, Benjamin ^a   Starnes, Vaughn A ^a,b,c   Schwarz, Margaret A ^a,b,d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Antiangiogenic; Endothelial monocyte activating polypeptide II; Myocardial infarction

Indexed keywords

ANTIANGIOGENIC PROTEIN; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE II; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL INVASION; CELL POPULATION; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSCRIPTION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SCAR; STROMA; VASCULARIZATION; WESTERN BLOTTING;

EID: 0347721100     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.06.001     Document Type: Article

References (42)

1. Li J., Brown L.F., Hibberd M.G., Grossman J.D., Morgan J.P., Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270:1996;H1803.
2. Shinohara K., Shinohara T., Mochizuki N., Mochizuki Y., Sawa H., Kohya T., Fujita M., Fujioka Y., Kitabatake A., Nagashima K. Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels. 11:1996;113.
3. Miyataka M., Ishikawa K., Katori R. Basic fibroblast growth factor increased regional myocardial blood flow and limited infarct size of acutely infarcted myocardium in dogs. Angiology. 49:1998;381.
4. Tomanek R.J., Zimmerman M.B., Suvarna P.R., Morkin E., Pennock G.D., Goldman S. A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. J. Mol. Cell Cardiol. 30:1998;923.
5. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., Ashare A.B., Lathi K., Isner J.M. Gene therapy for myocardial angiogenesis Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia . Circulation. 98:1998;2800.
6. Horrigan M.C., Malycky J.L., Ellis S.G., Topol E.J., Nicolini F.A. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model. Int. J. Cardiol. 10:1999;S85.
7. Schwarz M.A., Kandel J., Brett G., Li J., Hayward J., Schwarz R.E., Chappey O., Wautier J., Chabot J., Lo Gerfo P., Stern D. Endothelial-monocyte activating polypeptide II. A novel antitumor cytokine that suppresses primary and metastatic tumor growth, and induces apoptosis in growing endothelial cells. J. Exp. Med. 190:1999;341.
8. Kao J., Ryan J., Brett G., Chen J., Shen H., Fan Y.G., Godman G., Familletti P.C., Wang F., Pan Y.C., et al. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J. Biol. Chem. 267:1992;20239.
9. Kao J., Fan Y.G., Haehnel I., Clauss M., Stern D. Endothelial-monocyte activating polypeptides (EMAPs) Tumor derived mediators which activate the host inflammatory response . Behring Inst. Mitt. 92:1993;92.
10. Kao J., Houck K., Fan Y., Haehnel I., Libutti S.K., Kayton M.L., Grikscheit T., Chabot J., Nowygrod R., Greenberg S. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J. Biol. Chem. 269:1994;25106.
11. Ferrario A., Tiehl K., Rucker N., Schwarz M., Gill P., Gomer C. Anti-angiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 60:2000;4066.
12. Berger A.C., Alexander H.R., Tang G., Wu P.S., Hewitt S.M., Turner E., Kruger E., Figg W.D., Grove A., Kohn E., Stern D., Libutti S.K. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis. Microvasc. Res. 60:2000;70.
13. Schwarz M.A., Zhang F., Lane J.E., Schachtner S., Jin Y., Deutsch G., Starnes V., Pitt B.R. Angiogenesis and morphogenesis of murine fetal distal lung in an allograft model. Am. J. Physiol. Lung Cell Mol. Physiol. 278:2000;L1000.
14. Litwin S.E., Raya T.E., Warner A., Litwin C.M., Goldman S. Effects of captopril on contractility after myocardial infarction experimental observations . Am. J. Cardiol. 68:1991;26D.
15. Kim K.J., Li B., Winer J., Armanini M., Gillett N., Phillips H.S., Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature. 362:1993;841.
16. Plate K.H., Breier G., Weich H.A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 359:1992;845.
17. Losordo D.W., Vale P.R., Isner J.M. Gene therapy for myocardial angiogenesis. Am. Heart J. 138:1999;132.
18. Banai S., Jaklitsch M.T., Casscells W., Shou M., Shrivastav S., Correa R., Epstein S.E., Unger E.F. Effects of acidic fibroblast growth factor on normal and ischemic myocardium. Circ. Res. 69:1991;76.
19. Yanagisawa-Miwa A., Uchida Y., Nakamura F., Tomaru T., Kido H., Kamijo T., Sugimoto T., Kaji K., Utsuyama M., Kurashima C. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 257:1992;1401.
20. Battler A., Scheinowitz M., Bor A., Hasdai D., Vered Z., Di Segni E., Varda-Bloom N., Nass D., Engelberg S., Eldar M. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J. Am. Coll. Cardiol. 22:1993;2001.
21. Uchida Y., Yanagisawa-Miwa A., Nakamura F., Yamada K., Tomaru T., Kimura K., Morita T. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate An experimental study . Am. Heart J. 130:1995;1182.
22. Ueno H., Li J.J., Masuda S., Qi Z., Yamamoto H., Takeshita A. Adenovirus-mediated expression of the secreted form of basic fibroblast growth factor (FGF-2) induces cellular proliferation and angiogenesis in vivo. Arterioscler. Thromb. Vasc. Biol. 17:1997;2453.
23. Watanabe E., Smith D.M., Sun J., Smart F.W., Delcarpio J.B., Roberts T.B., Van M.C. Jr, Claycomb W.C. Effect of basic fibroblast growth factor on angiogenesis in the infarcted porcine heart. Basic Res. Cardiol. 93:1998;30.
24. Hasegawa T., Kimura A., Miyataka M., Inagaki M., Ishikawa K. Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction. Angiology. 50:1999;487.
25. Meng X., Brown J.M., Ao L., Shames B.D., Banerjee A., Harken A.H. Reduction of infarct size in the rat heart by LPS preconditioning is associated with expression of angiogenic growth factors and increased capillary density. Shock. 12:1999;25.
26. Schwarz E.R., Speakman M.T., Patterson M., Hale S.S., Isner J.M., Kedes L.H., Kloner R.A. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat - Angiogenesis and angioma formation. J. Am. Coll. Cardiol. 35:2000;1323.
27. Zhang F., Schwarz M.A. Temporo-spatial distribution of endothelial-monocyte activating polypeptide II. An anti-angiogenic protein, in the mouse embryo. Dev. Dyn. 218:2000;490.
28. Behrensdorf H.A., van de Craen M., Knies U.E., Vandenabeele P., Clauss M. The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7. FEBS Lett. 466:2000;143.
29. Daemen M.A., van't Veer C., Denecker G., Heeinskerk V.H., Wolfs T.G., Clauss M., Vandenabeele P., Buurman W.A. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J. Clin. Invest. 104:1999;541.
30. Palojoki E., Saraste A., Eriksson A., Pulkki K., Kallajoki M., Voipio-Pulkki L.M., Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am. J. Physiol. Heart Circ. Physiol. 280:2001;H2726.
31. Sam F., Sawyer D.B., Chang D.L., Eberli F.R., Ngoy S., Jain M., Amin J., Apstein C.S., Colucci W.S. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H422.
32. Abbate A., Melfi R., Patti G., Baldi F., D'Ambrosio A., Manzoli A., Baldi A., Di Sciascio G. Apoptosis in recent myocardial infarction. Clin. Ter. 151:2000;247.
33. Anversa P., Cheng W., Liu Y., Leri A., Redaelli G., Kajstura J. Apoptosis and myocardial infarction. Basic Res. Cardiol. 93:1998;8.
34. Dispersyn G.D., Mesotten L., Meuris B., Maes A., Mortelmans L., Flameng W., Ramaekers F., Borgers M. Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. Eur. Heart J. 23:2002;849.
35. Baldi A., Abbate A., Bussani R., Patti G., Melfi R., Angelini A., Dobrina A., Rossiello R., Silvestri F., Baldi F., Di Sciascio G. Apoptosis and post-infarction left ventricular remodeling. J. Mol. Cell Cardiol. 34:2002;165.
36. Ruetten H., Badorff C., Ihling C., Zeiher A.M., Dimmeler S. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects. J. Am. Coll. Cardiol. 38:2001;2063.
37. Zhang F.R., Schwarz M.A. Pro-EMAP II is not primarily cleaved by caspase-3 and-7. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L1239.
38. Norrby K. Mast cells and angiogenesis. APMIS. 110:2002;355.
39. Moldovan N.I. Role of monocytes and macrophages in adult angiogenesis A light at the tunnel's end . J. Hematother. Stem Cell Res. 11:2002;179.
40. Schmeisser A., Strasser R.H. Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells. J. Hematother. Stem Cell Res. 11:2002;69.
41. Kramer M.F., Kinscherf R., Aidonidis I., Metz J. Occurrence of a terminal vascularisation after experimental myocardial infarction. Cell Tissue Res. 291:1998;97.
42. Kalkman E.A., van Haren P., Saxena P.R., Schoemaker R.G. Regionally different vascular response to vasoactive substances in the remodelled infarcted rat heart; aberrant vasculature in the infarct scar. J. Mol. Cell Cardiol. 29:1997;1487.